Global Poultry Diagnostics Market

1 INTRODUCTION OF GLOBAL POULTRY DIAGNOSTICS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL POULTRY DIAGNOSTICS MARKET OUTLOOK
4.1 Overview

4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities

4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE
5.1 Avian Salmonellosis
5.2 Avian Influenza
5.3 Newcastle Disease
5.4 Avian Mycoplasmosis
5.5 Infectious Bronchitis
5.6 Infectious Bursal Disease
5.7 Avian Pasteurellosis
5.8 Avian Encephalomyelitis
5.9 Avian Reovirus
5.10 Chicken Anemia

6 GLOBAL POULTRY DIAGNOSTICS MARKET, BY SERVICES
6.1 Virology
6.2 Bacteriology
6.3 Parasitology

7 GLOBAL POULTRY DIAGNOSTICS MARKET, BY TEST TYPE
7.1 Enzyme-Linked Immunosorbent Assay (Elisa) Tests
7.2 Polymerase Chain Reaction (PCR) Tests
7.3 Other Diagnostic Tests

8 GLOBAL POULTRY DIAGNOSTICS MARKET, BY GEOGRAPHY
8.1 Overview

8.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico

8.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe

8.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific

8.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the World Regional Market Estimates and Forecasts, 2012 - 2025

9 GLOBAL POULTRY DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies

10 COMPANY PROFILES

10.1 Idexx Laboratories, Inc.
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments

10.2 Zoetis, Inc.
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments

10.3 Thermo Fisher Scientific Inc.
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments

10.4 Qiagen N.V.
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments

10.5 GD Animal Health
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments

10.6 IDVet
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments

10.7 Affinitech, Ltd.
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments

10.8 Agrobiotek Internacional
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments

10.9 Biochek
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments

10.10 Bionote, Inc.
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments

10.11 Boehringer Ingelheim GmbH
10.11.1 Overview
10.11.2 Financial Performance
10.11.3 Product Outlook
10.11.4 Key Developments

10.12 Bioingentech Biotechnologies, Inc.
10.12.1 Overview
10.12.2 Financial Performance
10.12.3 Product Outlook
10.12.4 Key Developments

10.13 Megacor Diagnostik GmbH
10.13.1 Overview
10.13.2 Financial Performance
10.13.3 Product Outlook
10.13.4 Key Developments

11 Appendix
11.1 Related Reports